Cleveland Clinic and IBM Unveil First Quantum Computer Dedicated to Healthcare Research
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
IBM has partnered with Cleveland Clinic to unveil the first onsite quantum computer in the U.S., dedicated to healthcare research. This deployment is a significant milestone in their 10-year Discovery Accelerator partnership, aimed at advancing biomedical discoveries using high-performance computing, artificial intelligence, and quantum technology. The IBM Quantum System One will assist researchers in identifying new medicines and treatments faster, addressing diseases like cancer and Alzheimer's. This collaboration also focuses on workforce education, creating job opportunities in data science and quantum computing.
Positive
- First quantum computer dedicated to healthcare research deployed at Cleveland Clinic.
- Partnership aims to accelerate biomedical discoveries using advanced computing.
- Will address significant health issues including cancer and Alzheimer's.
- Focus on workforce development through education and job creation.
Negative
- None.
Details
News Market Reaction – IBM
The recorded move for IBM in the trading session of this news was +0.50%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
IBM Quantum System One deployed at
CLEVELAND and
The unveiling comes as a key milestone in
Quantum computing is a rapidly emerging technology that harnesses the laws of quantum mechanics to solve problems that today's most powerful supercomputers cannot practically solve. The ability to tap into these new computational spaces could help researchers identify new medicines and treatments more quickly.
"This is a pivotal milestone in our innovative partnership with
"With the unveiling of IBM Quantum System One at
In addition to quantum computing, the Cleveland Clinic-IBM Discovery Accelerator draws upon a variety of
The Cleveland Clinic-IBM Discovery Accelerator has generated multiple projects that leverage the latest in quantum computing, AI and hybrid cloud to help expedite discoveries in biomedical research. These include:
- Development of quantum computing pipelines to screen and optimize drugs targeted to specific proteins;
- Improvement of a quantum-enhanced prediction model for cardiovascular risk following non-cardiac surgery; and
- Application of artificial intelligence to search genome sequencing findings and large drug-target databases to find effective, existing drugs that could help patients with Alzheimer's and other diseases.
The Discovery Accelerator also serves as the technology foundation for
A significant part of the collaboration is a focus on educating the workforce of the future and creating jobs to grow the economy. An innovative educational curriculum is being designed for participants from high school to the professional level, offering training and certification programs in data science, machine learning and quantum computing to build the skilled workforce needed for cutting-edge computational research of the future.
Additionally, the two organizations are hosting research symposia, seminars and workshops intended for academia, industry, government and the public with a goal of building a critical mass of computing specialists in
About
Visit us at clevelandclinic.org. Follow us at twitter.com/ClevelandClinic. News and resources available at newsroom.clevelandclinic.org.
About
Contacts:
281-455-6432
Sarah.benchaita@ibm.com
Cleveland Clinic
216-408-7444
Realeca@ccf.org
216-312-4755
westere@ccf.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/cleveland-clinic-and-ibm-unveil-first-quantum-computer-dedicated-to-healthcare-research-301776754.html
SOURCE